The Junctional Adhesion Molecule 3 (JAM-3) on Human Platelets is a Counterreceptor for the Leukocyte Integrin Mac-1
Top Cited Papers
Open Access
- 2 September 2002
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 196 (5), 679-691
- https://doi.org/10.1084/jem.20020267
Abstract
Read the full review for this F1000Prime recommended article: The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1.Keywords
This publication has 68 references indexed in Scilit:
- Cloning of Human Junctional Adhesion Molecule 3 (JAM3) and Its Identification as the JAM2 Counter-receptorPublished by Elsevier ,2001
- A Novel Protein with Homology to the Junctional Adhesion MoleculePublished by Elsevier ,2000
- Junctional Adhesion Molecule Interacts with the PDZ Domain-containing Proteins AF-6 and ZO-1Journal of Biological Chemistry, 2000
- Interaction of Junctional Adhesion Molecule with the Tight Junction Components ZO-1, Cingulin, and OccludinJournal of Biological Chemistry, 2000
- Vascular Endothelial Junction-associated Molecule, a Novel Member of the Immunoglobulin Superfamily, Is Localized to Intercellular Boundaries of Endothelial CellsPublished by Elsevier ,2000
- In‐vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β‐thalassaemia majorBritish Journal of Haematology, 1997
- A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2.Journal of Clinical Investigation, 1994
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Human neutrophils contain and bind high molecular weight kininogen.Journal of Clinical Investigation, 1989
- Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.Journal of Clinical Investigation, 1989